Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
RESEARCH TOOLSreports
Holding OLMA?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -34.55M | $ -30.38M | $ -30.97M | $ -30.42M | $ -23.34M |
| EBITDA | $ -34.17M | $ -30.00M | $ -30.59M | $ -30.33M | $ -23.25M |
| Net Income Common Stockholders | $ -34.55M | $ -30.38M | $ -30.97M | $ -26.77M | $ -21.50M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 214.76M | $ 239.10M | $ 248.98M | $ 261.81M | $ 276.90M |
| Total Assets | $ 230.17M | $ 254.56M | $ 263.69M | $ 276.94M | $ 292.80M |
| Total Debt | $ 1.70M | $ 1.96M | $ 2.21M | $ 2.42M | $ 2.62M |
| Net Debt | $ -213.06M | $ -237.14M | $ -246.77M | $ -259.39M | $ -274.28M |
| Total Liabilities | $ 31.26M | $ 27.39M | $ 27.38M | $ 23.05M | $ 17.66M |
| Stockholders Equity | $ 198.91M | $ 227.16M | $ 236.32M | $ 253.90M | $ 275.13M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -27.02M | $ -27.56M | $ -23.65M | $ -18.48M | $ -22.74M |
| Operating Cash Flow | $ -27.02M | $ -27.55M | $ -23.50M | $ -18.48M | $ -22.74M |
| Investing Cash Flow | $ 45.92M | $ -4.88M | $ -20.14M | $ -30.91M | $ -25.44M |
| Financing Cash Flow | $ 92.00K | $ 15.61M | $ 8.82M | $ 523.00K | $ 130.63M |